Potassium Ion

Potassium Ion

SCHEMBL6237094

C=CCN1CCc2c([nH]c3ccc(OC)cc23)C1C(=O)[O-].[K+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 7/20 0.63
MAPKAPK5 Q8IW41 1/20 0.48
SIRT1 Q96EB6 1/20 0.48
MAPT P10636 3/20 0.47
TP53 P04637 3/20 0.47
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTR2B P41595 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
BAZ2B Q9UIF8 1/20 0.43
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6239833 0.90 MAPKAPK2 (0.78) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6237433 0.89 MAPKAPK2 (0.64) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6354642 0.82 MAPKAPK2 (0.65) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6360694 0.78 MAPKAPK2 (0.62) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6241557 0.78 MAPKAPK2 (1.00) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6241878 0.77 MAPKAPK2 (0.78) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6274136 0.75 MAPKAPK2 (0.66) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL1658785 0.74 MAPKAPK2 (1.00) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6239272 0.74 MAPKAPK2 (0.80) MAPKAPK2MAPKAPK5SIRT1MAPTTP53
SCHEMBL6235510 0.73 MAPKAPK2 (0.81) MAPKAPK2MAPKAPK5SIRT1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050137220-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors PHARMACIA CORPORATION (US) 2005-06-23 US disclosed
WO-2005009370-A2 BETA-CARBOLINE COMPOUNDS AND ANALOGUES THEREOF AND THEIR USE AS MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS PHARMACIA CORPORATION (US) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137220-A1 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors MAPKAPK2, MAP4K2, MAP3K2 MAPKAPK2 1/4885MAPKAPK5 34/4885SIRT1 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.